Share

June 2014; 1 (1) Clinical/Scientific NotesOpen Access

Effective antituberculous therapy in a patient with CLIPPERS: New insights into CLIPPERS pathogenesis

Nicolas Mélé, Vincent Guiraud, Pierre Labauge, Catherine Oppenheim, Jean Louis Mas, Guillaume Taieb
First published April 24, 2014, DOI: https://doi.org/10.1212/NXI.0000000000000006
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1032

Share

Article Information

vol. 1 no. 1 e6
DOI: 
https://doi.org/10.1212/NXI.0000000000000006
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received January 16, 2014
  • Accepted in final form March 19, 2014
  • First Published April 24, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Nicolas Mélé, MD,
    2. Vincent Guiraud, MD,
    3. Pierre Labauge, MD, PhD,
    4. Catherine Oppenheim, MD, PhD,
    5. Jean Louis Mas, MD, PhD and
    6. Guillaume Taieb, MD
  1. Nicolas Mélé, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Vincent Guiraud, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Pierre Labauge, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Catherine Oppenheim, MD, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Neuroradiology, associate editor (untill 2013 Neuroradiology, associate editor (since 2014)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Jean Louis Mas, MD, PhD and
    6. Scientific Advisory Boards:

    1. (1) Bayer (2) Boehringer-Ingelheim (3) Bristol-Myer-Squibb (4) Daiichi-Sankyo

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1) Bayer, honoraria 2) Boehringer-Ingelheim, honoraria 3) Bristol-Myer-Squibb, honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) French Ministry of Health, 1 grant, coordination of a randomized clinical trial, ongoing (2) INSERM Institut National Scientifique Et de la Recherche Medicale, financing a Stroke Research Unit, ongoing

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Guillaume Taieb, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (N.M., V.G., J.L.M.) and Department of Neuroradiology (C.O.), Université Paris-Descartes, Sorbonne Paris Cité, INSERM UMR 894, Centre Hospitalier Sainte-Anne, Paris, France; Department of Neurology (P.L.), CHU Montpellier, Hôpital Gui de Chauliac, Montpellier, France; and Department of Neurology (G.T.), CHU Nîmes, Hôpital Caremeau, Nîmes, France.
  1. Correspondence to Dr. Taieb: taiebguillaume{at}gmail.com
View Full Text

Article usage

Article usage: April 2014 to April 2022

AbstractFullPdfSource
Apr 2014712136Highwire
May 2014110447101Highwire
Jun 2014302101125Highwire
Jul 2014532238Highwire
Aug 2014201813Highwire
Sep 2014201813Highwire
Oct 201424424Highwire
Nov 2014221110Highwire
Dec 2014101131Highwire
Jan 20151086Highwire
Jan 201504719pmc
Feb 20151056Highwire
Feb 201501712pmc
Mar 2015121011Highwire
Mar 20150128pmc
Apr 20151366Highwire
Apr 20150198pmc
May 201521613Highwire
May 20150145pmc
Jun 20151027Highwire
Jun 20150136pmc
Jul 201512611Highwire
Jul 20150105pmc
Aug 201539513Highwire
Aug 20150148pmc
Sep 20159115Highwire
Sep 20150197pmc
Oct 2015865Highwire
Oct 20150118pmc
Nov 20152142Highwire
Nov 201501912pmc
Dec 2015656Highwire
Dec 201502513pmc
Jan 201612103Highwire
Jan 201602117pmc
Feb 2016732Highwire
Feb 2016054pmc
Mar 2016520Highwire
Mar 20160134pmc
Apr 2016772Highwire
Apr 20160115pmc
May 20162153Highwire
May 2016085pmc
Jun 20161662Highwire
Jun 2016062pmc
Jul 201622223Highwire
Jul 20160116pmc
Aug 20162263Highwire
Aug 2016073pmc
Sep 2016812Highwire
Sep 2016022pmc
Oct 20161042Highwire
Oct 20160174pmc
Nov 2016934Highwire
Nov 2016055pmc
Dec 2016541Highwire
Dec 2016082pmc
Jan 2017642Highwire
Jan 2017031pmc
Feb 2017300Highwire
Feb 2017055pmc
Mar 2017911Highwire
Mar 2017082pmc
Apr 2017514Highwire
Apr 2017365pmc
May 2017611Highwire
May 2017466pmc
Jun 2017322pmc
Jul 2017430Highwire
Jul 20177119pmc
Aug 2017433Highwire
Aug 2017155pmc
Sep 2017212Highwire
Sep 2017242pmc
Oct 2017801Highwire
Oct 2017023pmc
Nov 2017316Highwire
Nov 2017088pmc
Dec 2017062Highwire
Jan 2018093Highwire
Feb 20180588Highwire
Mar 20180901Highwire
Apr 20180723Highwire
May 20181732Highwire
Jun 20180537Highwire
Jun 20188912pmc
Jul 20180571Highwire
Aug 20181331Highwire
Aug 2018133pmc
Sep 20180271Highwire
Oct 20180432Highwire
Nov 20180485Highwire
Dec 201801174Highwire
Jan 201931066Highwire
Feb 20196886Highwire
Mar 20193329Highwire
Apr 20191146Highwire
May 20195207Highwire
Jun 20193158Highwire
Jul 20192135Highwire
Aug 20192139Highwire
Sep 2019255Highwire
Oct 2019282Highwire
Nov 20190113Highwire
Dec 2019055Highwire
Jan 2020283Highwire
Feb 2020083Highwire
Mar 2020033Highwire
Apr 2020043Highwire
May 20200113Highwire
Jun 2020194Highwire
Jul 2020040Highwire
Aug 2020054Highwire
Sep 2020372Highwire
Oct 2020274Highwire
Nov 2020075Highwire
Dec 2020192Highwire
Jan 20211108Highwire
Feb 2021183Highwire
Mar 2021086Highwire
Apr 2021136Highwire
May 20210124Highwire
Jun 20212101Highwire
Jul 20212108Highwire
Aug 20211619Highwire
Sep 2021073Highwire
Oct 202121617Highwire
Nov 202111617Highwire
Dec 20212155Highwire
Jan 20221104Highwire
Feb 2022187Highwire
Mar 20221193Highwire
Apr 20221102Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Advertisement